These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8495425)

  • 1. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression.
    Moshier JA; Dosescu J; Skunca M; Luk GD
    Cancer Res; 1993 Jun; 53(11):2618-22. PubMed ID: 8495425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ornithine decarboxylase transformation of NIH/3T3 cells is mediated by altered epidermal growth factor receptor activity.
    Moshier JA; Malecka-Panas E; Geng H; Dosescu J; Tureaud J; Skunca M; Majumdar AP
    Cancer Res; 1995 Nov; 55(22):5358-65. PubMed ID: 7585601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM; Pegg AE
    Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of ornithine decarboxylase in a transformed cell line that overexpresses translation initiation factor eIF-4E.
    Shantz LM; Hu RH; Pegg AE
    Cancer Res; 1996 Jul; 56(14):3265-9. PubMed ID: 8764119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
    Hurta RA; Lee J; Voskas D
    J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of an ornithine decarboxylase dominant-negative mutant reverses eukaryotic initiation factor 4E-induced cell transformation.
    Shantz LM; Coleman CS; Pegg AE
    Cancer Res; 1996 Nov; 56(22):5136-40. PubMed ID: 8912847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation.
    Shantz LM; Pegg AE
    Cancer Res; 1994 May; 54(9):2313-6. PubMed ID: 8162572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
    Voskas D; Mader R; Lee J; Hurta RA
    Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice.
    Auvinen M; Laine A; Paasinen-Sohns A; Kangas A; Kangas L; Saksela O; Andersson LC; Hölttä E
    Cancer Res; 1997 Jul; 57(14):3016-25. PubMed ID: 9230217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.
    Iwata S; Sato Y; Asada M; Takagi M; Tsujimoto A; Inaba T; Yamada T; Sakamoto S; Yata J; Shimogori T; Igarashi K; Mizutani S
    Oncogene; 1999 Jan; 18(1):165-72. PubMed ID: 9926931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of overexpression of ornithine decarboxylase (ODC) on growth control and oncogene-induced cell transformation.
    Hibshoosh H; Johnson M; Weinstein IB
    Oncogene; 1991 May; 6(5):739-43. PubMed ID: 1711188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human chromosome 2 ornithine decarboxylase gene in ornithine decarboxylase-deficient Chinese hamster ovary cells.
    Hsieh JT; Denning MF; Heidel SM; Verma AK
    Cancer Res; 1990 Apr; 50(8):2239-44. PubMed ID: 2317811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ornithine decarboxylase regulates the activity and localization of rhoA via polyamination.
    Mäkitie LT; Kanerva K; Andersson LC
    Exp Cell Res; 2009 Apr; 315(6):1008-14. PubMed ID: 19331812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation status and chromatin structure of an early response gene (ornithine decarboxylase) in resting and stimulated NIH-3T3 fibroblasts.
    Laitinen J; Hölttä E
    J Cell Biochem; 1994 Jun; 55(2):155-67. PubMed ID: 7522236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of polyamine biosynthesis alters intrinsic histone acetyltransferase and deacetylase activities in murine skin and tumors.
    Hobbs CA; Paul BA; Gilmour SK
    Cancer Res; 2002 Jan; 62(1):67-74. PubMed ID: 11782361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ornithine decarboxylase activity is critical for cell transformation.
    Auvinen M; Paasinen A; Andersson LC; Hölttä E
    Nature; 1992 Nov; 360(6402):355-8. PubMed ID: 1280331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable siRNA-mediated silencing of antizyme inhibitor: regulation of ornithine decarboxylase activity.
    Choi KS; Suh YH; Kim WH; Lee TH; Jung MH
    Biochem Biophys Res Commun; 2005 Mar; 328(1):206-12. PubMed ID: 15670771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression.
    Nilsson J; Grahn B; Heby O
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):699-704. PubMed ID: 10698696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ornithine decarboxylase gene expression is aberrantly regulated via the cAMP signal transduction pathway in malignant H-ras transformed cell lines.
    Hurta RA; Wright JA
    J Cell Physiol; 1994 Nov; 161(2):383-91. PubMed ID: 7525612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for protein kinase C-delta in the regulation of ornithine decarboxylase expression by oxidative stress.
    Otieno MA; Kensler TW
    Cancer Res; 2000 Aug; 60(16):4391-6. PubMed ID: 10969783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.